- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
- 10-K Annual report
- 10.2 Third Lease Amendment, Wake Forest University Health Sciences
- 10.15 Exclusive License Agreement
- 23.1 Consent of Ernst & Young LLP
- 31.1 Certification of Chief Executive Officer, Section 302
- 31.2 Certification of Chief Financial Officer, Section 302
- 32.1 Certification of Chief Executive Officer, Section 906
- 32.2 Certification of Chief Financial Officer, Section 906
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
• | Registration Statement (Form S-8 No. 333-133882) pertaining to the Targacept, Inc. 2000 Equity Incentive Plan, |
• | Registration Statements (Form S-8 No. 333-160331 and Form S-8 No. 333-133881) pertaining to the Targacept, Inc. 2006 Stock Incentive Plan, and |
• | Registration Statement (Form S-3 No. 333-171346) of Targacept, Inc.; |
of our reports dated March 06, 2012, with respect to the financial statements of Targacept, Inc. and the effectiveness of internal control over financial reporting of Targacept, Inc. included in this Annual Report (Form 10-K) of Targacept, Inc. for the year ended December 31, 2011.
/s/ Ernst & Young LLP
Raleigh, North Carolina
March 06, 2012